Skip to content

Agile Therapeutics, Inc.: filings

Every Agile Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 42 filings, each linked to its SEC index.

Filing record ends 2024-08-12

The latest filing in this captured record is a 10-Q filed 2024-08-12. No later filing is in the SEC companyfacts record captured on 2026-09-22. Agile Therapeutics, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2024-08-12fiscal Q2 2024441250001558370-24-011904
10-Q2024-05-15fiscal Q1 202444920001558370-24-008297
10-K2024-03-28fiscal FY 2023511310001558370-24-004262
10-Q2023-11-09fiscal Q3 2023471340001558370-23-018603
10-Q2023-08-09fiscal Q2 2023471300001558370-23-014296
10-Q2023-05-11fiscal Q1 202347940001558370-23-009400
10-K2023-03-23fiscal FY 2022512970001558370-23-004386
10-Q2022-11-07fiscal Q3 2022481420001558370-22-016628
10-Q2022-08-11fiscal Q2 2022481380001558370-22-013304
10-Q2022-05-12fiscal Q1 202248980001558370-22-008549
10-K2022-03-30fiscal FY 2021501190001558370-22-004758
10-Q/A2021-12-30fiscal Q3 2021481300001558370-21-017076
10-Q2021-11-02fiscal Q3 2021481300001558370-21-014107
10-Q2021-07-26fiscal Q2 2021441100001558370-21-009253
10-Q2021-05-04fiscal Q1 202144840001558370-21-005699
10-K2021-03-01fiscal FY 2020461190001558370-21-002163
10-Q2020-11-12fiscal Q3 202036910001558370-20-013706
10-Q2020-08-11fiscal Q2 202034830001558370-20-010330
10-Q2020-05-05fiscal Q1 202032620001558370-20-005210
10-K2020-02-20fiscal FY 2019351010001047469-20-000966
10-Q2019-10-28fiscal Q3 201932870001104659-19-056670
10-Q2019-08-01fiscal Q2 201933820001104659-19-043196
10-Q2019-05-03fiscal Q1 201933620001104659-19-026838
10-K2019-03-12fiscal FY 2018351060001047469-19-001136
10-Q2018-11-02fiscal Q3 201831780001104659-18-065593
10-Q2018-08-03fiscal Q2 201830770001104659-18-049513
10-Q2018-05-07fiscal Q1 201830610001104659-18-030911
10-K2018-03-12fiscal FY 2017351060001047469-18-001539
10-Q2017-11-06fiscal Q3 201728720001104659-17-066342
10-Q2017-07-28fiscal Q2 201728710001104659-17-047489
10-Q2017-05-08fiscal Q1 201723470001104659-17-030669
10-K2017-03-15fiscal FY 201626830001047469-17-001623
10-Q2016-11-07fiscal Q3 201623620001104659-16-155190
10-Q2016-08-08fiscal Q2 201623620001104659-16-137918
10-Q2016-05-09fiscal Q1 201623480001104659-16-119225
10-K2016-03-09fiscal FY 201528980001047469-16-010929
10-Q2015-11-09fiscal Q3 201525650001104659-15-077262
10-Q2015-08-13fiscal Q2 201525650001104659-15-059584
10-Q2015-05-12fiscal Q1 201529580001104659-15-037282
10-K2015-03-26fiscal FY 201428970001047469-15-002798
10-Q2014-11-13fiscal Q3 201422570001104659-14-080409
10-Q2014-08-14fiscal Q2 201423590001104659-14-061061

Inspect the source

Entity
Agile Therapeutics, Inc. / CIK 0001261249
Captured
SEC response SHA-256
dfa60388e3d618cfe1a780836e21d55d8bef6ac848684cf8fd7d6373390ae6f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001261249.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))